ginsenoside rh2 has been researched along with Cystadenocarcinoma, Serous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirata, J; Imaizumi, E; Kikuchi, Y; Kita, T; Nagata, I; Tode, T | 1 |
1 other study(ies) available for ginsenoside rh2 and Cystadenocarcinoma, Serous
Article | Year |
---|---|
[Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Cystadenocarcinoma, Serous; Female; Ginsenosides; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Saponins | 1993 |